APR 02, 2018 08:37 PM PDT

'Fish Hooks' Speed Up Drug Discovery

WRITTEN BY: Nouran Amin
2 2 150

 

DNA-encoded chemical library (DECL), containing about 35 million different drugs, is a new screening method developed to speed up drug discovery.

The collection of drug candidates consist of basic ring-shaped structures based on the work of Manfred Mutter from the University of Lausanne where three different molecules were attached to one side of each ring structure. “Together, they form a kind of highly-specific fish hook that can bind onto a protein if its form perfectly matches the protein’s structure,” says lead researcher Jörg Scheuermann of ETH Zurich. Now, DECL researchers use the library for all kinds of “fish hooks” creating various combinations.

Investigators encoded the blueprint of these molecules in short DNA sequences where the genetic material was bound to the reverse of the basic structure producing an artificial piece of DNA that serves as a “barcode”. Investigators can use such barcode to identify each fish hook individually. This can allow the ability to detect a target protein caught by one of the “fish hooks”. So, researchers placed all 35 million compounds a reaction vessel containing the protein of interest. After a period of time ,they washed the chemical collection away hoping that those drugs that failed to bind to the carrier protein were discarded, and those that succeeded in binding remained in the vessel. Those drugs that were not washed away were identified using DNA barcodes. The identifications of those remaining in the sample can allow researchers to further potential testing and narrow down their options until a match is made.

Image via Phys.org

The development of DECLs was in works for years. The basics of DECLs which are the essential foundations of DNA-encoding were first described in the early 1990s by Scripps researchers Richard Lerenr and Sidney Brenner but was not put into practice until a decade later when researchers at Harvard University worked on the idea and later presented the first DNA-encoding chemical collection.

The progress of DECL has been crucial in the pharmaceutical industry due to its inexpensiveness and efficacy. “The design of our DECL is based on the fact that we wanted to generate a new molecule form that would be functionally equivalent to an antibody reduced to its minimum size, and therefore accessible via chemical synthesis,” explains Scheuermann. “By using molecules that possess three or more chemical hooks, we come closer to antigen-antibody interactions.”

A proposed treatment option involves linking a particular protein known as a cytotoxin to a small-molecule drug conjugate, protein binder. This approach allows the cytotoxin to recognize a foreign invader or tumor cell, bind to it, and release the toxic activity in a localized concentration, leading to tumor cellular death. This method was previously used with antibodies as antibody-drug conjugates (ADC).“However, as antibodies are relatively large, they were not able to penetrate tumor tissue well; small molecules should be able to accomplish this better,” explains Scheuermann.

Sources: Nature Chemistry

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
MAR 12, 2018
Drug Discovery
MAR 12, 2018
Treating Hearing Loss: A Set of Inhibiting Drugs Provide Promising Results
Our inner ears contain roughly 30,000 tiny hair cells that work to detect sound waves as well as to translate these waves into nerve signals. The nerve sig
APR 14, 2018
Drug Discovery
APR 14, 2018
A Digitalized Drug-Free Treatment for Panic Disorders
A drug-free treatment known as Freespira® was developed by a digitalized therapeutic company, Palo Alto Health Sciences, Inc. (PAHS), for the treatment
MAY 03, 2018
Drug Discovery
MAY 03, 2018
Re-Designing Treatments for Alzheimer Disease
The most common form of dementia is Alzheimer which is a general term for memory loss and other cognitive abilities that complicate activities of daily lif
JUN 13, 2018
Drug Discovery
JUN 13, 2018
Small Molecule Seeks To Treat Asthma Attacks
For many individuals with asthma, a tiny particle almost invisible can trigger an asthmatic attack if it enters the airways of the respiratory system. Asth
JUN 20, 2018
Drug Discovery
JUN 20, 2018
New Drug 'Moxidectin' for River Blindness
A new treatment to help eliminate a neglected tropical disease was developed thanks in part to an incentive program devised by researchers at Duke Universi
JUL 21, 2018
Genetics & Genomics
JUL 21, 2018
Designer Cells Sense & Destroy MRSA
Staphylococcus aureus is thought to lead to over 11 million visits to the doctor and the ER every year in the US alone.
Loading Comments...